Vor Biopharma (VOR) Prepaid Assets (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Prepaid Assets of $6.4 million for Q1 2026, up 2052.86% year-over-year from $297000.0 in Q1 2025, and up 266.42% quarter-over-quarter from $1.7 million in Q4 2025.
Vor Biopharma (VOR) Prepaid Assets (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Prepaid Assets for 7 consecutive years, with $6.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 2052.86% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 2052.86% YoY), while the FY2025 annual figure was $1.7 million, up 359.21% from the prior year.
- Prepaid Assets improved to $6.4 million in Q1 2026 per VOR's latest filing, from $1.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.4 million in Q1 2026 and bottomed at $285000.0 in Q3 2024.
- Historically, Prepaid Assets has averaged $2.8 million across 5 years, with a median of $2.2 million in 2022.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 92.24% — and 2026, when it jumped 2052.86%.
- Vor Biopharma's Prepaid Assets stood at $4.4 million in 2022, then plunged by 89.13% to $475000.0 in 2023, then slipped by 20.0% to $380000.0 in 2024, then soared by 359.21% to $1.7 million in 2025, then surged by 266.42% to $6.4 million in 2026.
- Business Quant data shows VOR's Prepaid Assets at $6.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.88 Mn |
| Mar 31, 2026 | 6.39 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 297,000.00 |
| Dec 31, 2024 | 380,000.00 |
| Sep 30, 2024 | 285,000.00 |
| Jun 30, 2024 | 4.05 Mn |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 475,000.00 |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 3.95 Mn |
| Mar 31, 2023 | 6.24 Mn |
| Dec 31, 2022 | 4.37 Mn |
| Sep 30, 2022 | 4.89 Mn |
| Jun 30, 2022 | 5.47 Mn |
| Mar 31, 2022 | 2.21 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Sep 30, 2021 | 749,000.00 |